Dose–Response Association Between Handgrip Strength and All‐Cause Mortality Across Different Levels of Systemic Inflammation

Read full text Summarise with VIRAT
Authors: Andrea Tur‐Boned, Lars L. Andersen, Rubén López‐Bueno, Rodrigo Núñez‐Cortés, Carlos Cruz‐Montecinos, Luis Suso‐Martí, Ana Polo‐López, Joaquín Calatayud
Cited by: 0
References: 47

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Longitudinal associations between C-reactive protein (CRP) and handgrip strength from cohort studies remain inconsistent. We investigated the dose-response association between handgrip strength and all-cause mortality across different levels of systemic inflammation. METHODS: We analysed data from 20 941 participants (mean age 68 years ±9.4 SD; 43.1% men) from the Survey of Health, Ageing and Retirement in Europe (SHARE) Waves 6 to 9. CRP levels were categorized as > 3, > 10 and > 25 mg/L. Time-varying Cox proportional hazards regression with restricted cubic splines modeled associations between handgrip strength and all-cause mortality, adjusting for age, sex, BMI, smoking, education, marital status, geographic region and medications. RESULTS: During 4.8-5.3 years follow-up, mortalities were 14.7% (CRP > 3 mg/L), 22.5% (CRP > 10 mg/L) and 30.2% (CRP > 25 mg/L). A curvilinear dose-response association existed between handgrip strength and mortality across all CRP levels with a significant interaction found between CRP and handgrip strength (p = 0.0131). Using median handgrip strength as reference (30 kg for CRP > 3 mg/L; 28 kg for CRP > 10 and > 25 mg/L), participants at the 10th percentile showed hazard ratios of 1.84 (95% CI 1.59-2.14), 1.69 (95% CI 1.33-2.15) and 1.92 (95% CI 1.17-3.17), respectively. Participants at the 90th percentile demonstrated protective effects: HR 0.57 (95% CI 0.43-0.74), 0.50 (95% CI 0.30-0.82) and 0.38 (95% CI 0.17-0.87). CONCLUSIONS: Handgrip strength demonstrates a strong inverse dose-response association with mortality across varying inflammation levels. Protective effects persist even with elevated inflammatory markers, supporting handgrip strength as an accessible biomarker for mortality risk stratification in older adults regardless of inflammatory status.

Fields of Study & Subjects

Nutrition and Health in Aging Inflammatory Biomarkers in Disease Prognosis Frailty in Older Adults

Publication details

Journal / source
Journal of Cachexia Sarcopenia and Muscle
Volume
17
Issue
2
Pages
e70272–e70272
Publication date
27 March 2026
Language
EN